Atridox is a sublingual controlled-release product composed of a two syringe mixing system. One syringe contains 450 mg of the Atrigel Delivery System and the second contains 50 mg of doxycycline hyclate. When the reconstituted product comes into contact with crevicular fluid, the liquid solidifies and allows the controlled release of the drug for a period of up to seven days.
Drug Name: Atridox
Generic name: Doxycycline hyclate